2,3-dimethylmaleic anhydride has been researched along with methotrexate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, N; Hara, T; Kato, Y; Takeda, Y; Umemoto, N | 1 |
| Cao, Z; Hua, Z; Li, Y; Liu, R; Liu, Y; Lu, A; Lu, C; Luo, X; Wang, X; Xue, Z; Zhang, Z | 1 |
2 other study(ies) available for 2,3-dimethylmaleic anhydride and methotrexate
| Article | Year |
|---|---|
A novel covalent modification of antibodies at their amino groups with retention of antigen-binding activity.
Topics: Amines; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Binding Sites, Antibody; Chemical Phenomena; Chemistry; Maleic Anhydrides; Melanoma; Melanoma-Specific Antigens; Methotrexate; Mice; Neoplasm Proteins | 1987 |
MTX-PEG-modified CG/DMMA polymeric micelles for targeted delivery of doxorubicin to induce synergistic autophagic death against triple-negative breast cancer.
Topics: Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Female; Humans; Methotrexate; Micelles; Polymers; Triple Negative Breast Neoplasms | 2023 |